Cyclic AMP is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
=== Folklore === "Living water" features in Germanic and Slavic folktales as a means of bringing the dead back to life. Note the Grimm fairy-tale ("The Water of Life") and the Russian dichotomy of living and dead water. The Fountain of Youth represents a related concept of magical waters allegedly preventing aging.
==== MeSH D13.570.583 – purine nucleosides ==== MeSH D13.570.583.138 – adenosine MeSH D13.570.583.138.025 – adenosine-5'-(n-ethylcarboxamide) MeSH D13.570.583.138.240 – s-adenosylhomocysteine MeSH D13.570.583.138.264 – s-adenosylmethionine MeSH D13.570.583.138.300 – 2-chloroadenosine MeSH D13.570.583.138.300.200 – cladribine MeSH D13.570.583.138.325 – deoxyadenosines MeSH D13.570.583.138.325.075 – cladribine MeSH D13.570.583.138.325.105 – dideoxyadenosine MeSH D13.570.583.138.325.800 – puromycin aminonucleoside MeSH D13.570.583.138.500 – isopentenyladenosine MeSH D13.570.583.138.630 – phenylisopropyladenosine MeSH D13.570.583.138.711 – puromycin MeSH D13.570.583.138.711.650 – puromycin aminonucleoside MeSH D13.570.583.138.900 – vidarabine MeSH D13.570.583.454 – guanosine MeSH D13.570.583.454.240 – deoxyguanosine MeSH D13.570.583.454.500 – nucleoside q MeSH D13.570.583.616 – inosine MeSH D13.570.583.616.130 – didanosine MeSH D13.570.583.616.450 – inosine pranobex MeSH D13.570.583.616.900 – thioinosine MeSH D13.570.583.616.900.500 – methylthioinosine MeSH D13.570.583.910 – tubercidin
== Forensic detection == Worldwide, certain traditional Chinese medicines contain wild bear bile, banned under CITES legislation. Dip sticks, similar to common pregnancy tests, have been developed to detect the presence of bear albumin in traditional medicine products, indicating that bear bile had been used in their creation.
Sources: en.wikipedia.org
==== Johnson v. Zuffa ==== Based on court filings from late July 2025, the Johnson v. Zuffa antitrust lawsuit, originally filed in 2021, is proceeding, and status conference for the case is scheduled for late August 2025.
A small combination of these enhancer-bound transcription factors, when brought close to a promoter by a DNA loop, govern transcription level of the target gene. Mediator (a complex usually consisting of about 26 proteins in an interacting structure) communicates regulatory signals from enhancer DNA-bound transcription factors directly to the RNA polymerase II (pol II) enzyme bound to the promoter. Enhancers, when active, are generally transcribed from both strands of DNA with RNA polymerases acting in two different directions, producing two eRNAs as illustrated in the figure. An inactive enhancer may be bound by an inactive transcription factor. Phosphorylation of the transcription factor may activate it and that activated transcription factor may then activate the enhancer to which it is bound (see small red star representing phosphorylation of transcription factor bound to enhancer in the illustration). An activated enhancer begins transcription of its RNA before activating transcription of messenger RNA from its target gene.
In mouse leukemia model driven by fusion oncoprotein, condensate arrest suppressed target gene expression and inhibited cell proliferation. These findings provide mechanistic support for the functional relevance of the condensate microenvironment. Together, these studies establish the condensate microenvironment as a key mechanism in the regulation of biochemical specificity, localization, and activity within cells.
Sources: en.wikipedia.org
He coined the term "2C", this term being an acronym for the two carbon atoms between the benzene ring and the amino group of the 2C drugs and a means to distinguish them from the three-carbon DOx drugs. 2C-D was extensively studied by Hanscarl Leuner under the names DMM-PEA and LE-25 in psychedelic-assisted psychotherapy in Germany in the 1970s and 1980s. It was also informally studied by Darrell Lemaire as a potential "smart drug" in the 1970s and 1980s. He additionally developed the TWEETIO drugs such as 2CD-5-ETO via structural modification of the 2Cs. 2C-B was legitimately marketed and sold as an over-the-counter sexual enhancer under brand names like Erox in several European countries such as Germany in the 1980s and early 1990s. It was sold in adult stores, smart shops, and some nightclubs. 2C-B was first encountered as a novel designer drug in the United States in 1979. It gained popularity as a recreational drug and MDMA (ecstasy) alternative in the mid-1980s. The drug became a controlled substance in the United States in 1994 or 1995. It has been said to be the most popular of the 2C drugs in terms of recreational use. Numerous other 2C drugs besides 2C-B have also since been made controlled substances.
Another benefit with surgical intervention is visualization and evacuation of any condral fragments or loose bodies that may increase arthritis risk, lead to decreased range of motion of the joint as well as pain. In some instances, primarily seen with femoral head fractures on the weight bearing surface of the bone, joint replacement is indicated. The femoral head is known for leading to avascular necrosis and ORIF is not sufficient to maintain the blood supply to the fractured fragment. Therefore, replacement of the femoral head with a hemiarthroplasty or total hip arthroplasty is indicated in this case.
== Evolution == Based on parsimony-based phylogenetic analysis, the most recent common ancestor of all eukaryotes most likely already possessed an early RNAi pathway; the absence of the pathway in certain eukaryotes is thought to be a derived characteristic. This ancestral RNAi system probably contained at least one Dicer-like protein, one Argonaute, one PIWI protein, and an RNA-dependent RNA polymerase that may also have played other cellular roles. A large-scale comparative genomics study likewise indicates that the eukaryotic crown group already possessed these components, which may then have had closer functional associations with generalized RNA degradation systems such as the exosome. This study also suggests that the RNA-binding Argonaute protein family, which is shared among eukaryotes, most archaea, and at least some bacteria (such as Aquifex aeolicus), is homologous to and originally evolved from components of the translation initiation system.
. The complexation of a metal ion implies therefore the replacement of the coordinated water molecules with the respective ligands. The speed of this substitution plays a crucial role in the complexation kinetics and the following extraction processes. The replacement can be slow for an inert complex or rapid for a labile complex. The ligand could replace all the coordinated water molecules to form an inner sphere complex or just some of them for an outer-sphere complex. The complexation reaction is theoretically based on the Pearson's theory of hard and soft acids and bases, according to which hard acids form strong complexes with hard bases and likewise soft acids form strong complexes with soft bases. In aqueous solutions, hard-hard interactions are electrostatic, while soft-soft interactions usually show a covalent character. The formation of strong complexes always implies either a large gain of entropy or a large decrease of enthalpy thereby obtaining a large negative value of the complexation free energy. According to Pearson's theory, lanthanide and actinide ions are considered hard acids, thus they bind especially with ligands bearing hard donors such as oxygen atoms by electrostatic interactions. The charge of actinide and lanthanide ions in solution is substantially +3 and the difference in size of these cations is very small. Thus, an efficient separation of minor actinides from lanthanides is very challenging.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.